chrM-7445-A-T
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 1P and 0B. PM5_Supporting
This summary comes from the ClinGen Evidence Repository: The m.7445A>T (p.*514S) variant in MT-CO1 has been reported in one individual with primary mitochondrial disease to date (PMID:18639500). This person was Chinese and had severe hearing loss onset at age one year. There was no known precipitating event. The variant was homoplasmic in blood. There was no family history of hearing loss. This variant is present in population databases (Mitomap's 51,863 sequences: AF=0.049%; Helix's 196,554 sequences: AF=0.002%; gnomAD v3.1.2: absent). There are no in-silico prediction tools for a stop-loss variant in mitochondrial DNA, although this variant would not be expected to cause run-through due to the excision of the tRNA immediately adjacent. Another variant at this position has been classified as pathogenic – m.7445A>G (PM5_supporting). In summary, this variant meets criteria to be classified as uncertain significance for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on July 8, 2024. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID:32906214): PM5_supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA414792846/MONDO:0044970/015
Frequency
Consequence
ENST00000361624.2 stop_lost, splice_region
Scores
Clinical Significance
Conservation
Publications
- mitochondrial diseaseInheritance: Mitochondrial Classification: DEFINITIVE Submitted by: ClinGen
- MERRF syndromeInheritance: Mitochondrial Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: ENST00000361624.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MT-CO1 | ENST00000361624.2 | TSL:6 | c.1542A>T | p.Ter514Serext*? | stop_lost splice_region | Exon 1 of 1 | ENSP00000354499.2 | ||
| MT-CO2 | ENST00000361739.1 | TSL:6 | c.-141A>T | upstream_gene | N/A | ENSP00000354876.1 | |||
| MT-TD | ENST00000387419.1 | TSL:6 | n.-73A>T | upstream_gene | N/A |
Frequencies
Mitomap
ClinVar
Submissions by phenotype
Mitochondrial non-syndromic sensorineural hearing loss Pathogenic:1Other:1
Mitochondrial disease Uncertain:1
The m.7445A>T (p.*514S) variant in MT-CO1 has been reported in one individual with primary mitochondrial disease to date (PMID: 18639500). This person was Chinese and had severe hearing loss onset at age one year. There was no known precipitating event. The variant was homoplasmic in blood. There was no family history of hearing loss. This variant is present in population databases (Mitomap's 51,863 sequences: AF=0.049%; Helix's 196,554 sequences: AF=0.002%; gnomAD v3.1.2: absent). There are no in-silico prediction tools for a stop-loss variant in mitochondrial DNA, although this variant would not be expected to cause run-through due to the excision of the tRNA immediately adjacent. Another variant at this position has been classified as pathogenic – m.7445A>G (PM5_supporting). In summary, this variant meets criteria to be classified as uncertain significance for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on July 8, 2024. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID: 32906214): PM5_supporting.
Computational scores
Source: